Safety, tolerance, and pharmacokinetics of amphotericin B lipid advanced in children with hepatosplenic candidiasis. Efficacy and safety of amphotericin B lipid complex in 548 youngsters and adolescents with invasive fungal infections. Retrospective evaluation of the dosage of amphotericin B lipid advanced for the therapy of invasive fungal infections. Linear pharmacokinetics of micafungin and its active metabolites in Japanese pediatric patients with fungal infections. Posaconazole plasma concentrations in juvenile patients with invasive fungal infection. Posaconazole for the therapy of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. A randomized, double-blind trial of anidulafungin versus fluconazole for the therapy of esophageal candidiasis. A randomized double-blind study of caspofungin versus fluconazole for the therapy of esophageal candidiasis. Caspofungin therapy of neonates with invasive candidiasis. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic topics. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia.
